Supplementary Materials
overweight
HEART, OBESE
ESM_File _S1: CONSORT checklist, study diagram, and tables. This file contains the Consolidated Standards of Reporting Trials (CONSORT) checklist and a study diagram. Table 1S contains a summary of additional study participant demographics, physical activity levels, and hemoglobin A1c. Tables 2S and 3S are the effects of age and gender on the heart rate variability changes induced by the jogging device (JD). Table 4S shows the differences between 7 days of jogging device (JD7) and 7 days after completion of JD (Post-JD) and baseline (BL) for parameters of the HRV for the entire study group.Click here for additional data file.Photographs of the passive simulated jogging device (JD). The photograph depicts a close-up of the JD (a), a seated subject multitasking and working on a desk (b), and a seated subject on a couch (c) with the feet on the passive simulated jogging device (JD).Effects of JD on the linear and Poincaré parameters of HRV. The effects of jogging device (JD) on linear parameters of HRV; (a) standard deviation of all normal RR intervals (SDNN); (b) standard deviation of the delta of all RR intervals (SDStudy participants' characteristics.This table represents the study participants characteristics: study subject number (No), gender, age range (years), calculated body mass index (BMI) (nl: normal weight; ow: overweight; ob: obese), baseline blood pressure (systolic/diastolic), and current medications. Mean and standard deviation (SD) for each column. Effects of JD on parameters of heart rate variability.Parameters of heart rate variability at baseline (BL), after 7 days of the jogging device (JD7), and 7 days after discontinuation of JD (Post-JD). Heart rate (beats per minute (BPM), standard deviation of all normal RR intervals (SDNN), standard deviation of the delta of all RR intervals (SD